In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
After finishing at $90.20 in the prior trading day, Colgate-Palmolive Co (NYSE: CL) closed at $90.15, down -0.06%. In other words, the price has decreased by -$0.06 from its previous closing price. On the day, 5.12 million shares were traded.
Ratios:
Our goal is to gain a better understanding of CL by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 55.73 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 21.07. For the most recent quarter (mrq), Quick Ratio is recorded 0.54 and its Current Ratio is at 0.85. In the meantime, Its Debt-to-Equity ratio is 22.78 whereas as Long-Term Debt/Eq ratio is at 18.10.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Stifel on October 28, 2024, Downgraded its rating to Hold and sets its target price to $101 from $105 previously.
On September 24, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $121. Wells Fargo Downgraded its Equal Weight to Underweight on September 16, 2024, while the target price for the stock was maintained at $100.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 15 ’25 when Massey Sally sold 2,250 shares for $88.97 per share. The transaction valued at 200,183 led to the insider holds 12,583 shares of the business.
Massey Sally sold 8,000 shares of CL for $736,152 on Feb 25 ’25. The Chief Human Resources Officer now owns 14,805 shares after completing the transaction at $92.02 per share. On Nov 26 ’24, another insider, Malcolm Gregory, who serves as the EVP and Controller of the company, sold 1,054 shares for $95.94 each. As a result, the insider received 101,121 and left with 9,620 shares of the company.
Valuation Measures:
As of this moment, Colgate-Palmolive’s Price-to-Earnings (P/E) ratio for their current fiscal year is 25.53, and their Forward P/E ratio for the next fiscal year is 22.94. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 4.56. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.66 while its Price-to-Book (P/B) ratio in mrq is 201.26.
Stock Price History:
Over the past 52 weeks, CL has reached a high of $109.30, while it has fallen to a 52-week low of $85.32. The 50-Day Moving Average of the stock is -1.94%, while the 200-Day Moving Average is calculated to be -4.37%.
Shares Statistics:
A total of 810.42M shares are outstanding, with a floating share count of 809.14M. Insiders hold about 0.16% of the company’s shares, while institutions hold 107.74% stake in the company.
Earnings Estimates
At present, 16.0 analysts are actively evaluating the performance of Colgate-Palmolive Co (CL) in the stock market.The consensus estimate for the next quarter is $0.91, with high estimates of $0.93 and low estimates of $0.88.
Analysts are recommending an EPS of between $3.85 and $3.55 for the fiscal current year, implying an average EPS of $3.67. EPS for the following year is $3.94, with 19.0 analysts recommending between $4.09 and $3.82.
Revenue Estimates
11 analysts predict $5.03B in revenue for the current quarter. It ranges from a high estimate of $5.08B to a low estimate of $4.97B. As of the current estimate, Colgate-Palmolive Co’s year-ago sales were $5.06BFor the next quarter, 11 analysts are estimating revenue of $5.16B. There is a high estimate of $5.2B for the next quarter, whereas the lowest estimate is $5.14B.
A total of 17 analysts have provided revenue estimates for CL’s current fiscal year. The highest revenue estimate was $20.4B, while the lowest revenue estimate was $20.15B, resulting in an average revenue estimate of $20.27B. In the same quarter a year ago, actual revenue was $20.1BBased on 17 analysts’ estimates, the company’s revenue will be $21.07B in the next fiscal year. The high estimate is $21.31B and the low estimate is $20.77B.
